{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:51:50Z","timestamp":1781002310903,"version":"3.54.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2784,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2007.08390.x","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T09:04:21Z","timestamp":1202720661000},"page":"496-504","source":"Crossref","is-referenced-by-count":31,"title":["Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines"],"prefix":"10.1093","volume":"158","author":[{"given":"A.","family":"Sorolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Yeramian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Dolcet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"P\u00e9rez de Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Llobet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Schoenenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Llombart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vilella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,1,17]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1470-2045(00)00290-4","article-title":"Vaccines for melanoma: translating basic immunology into new therapies","volume":"2","author":"Wolchok","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00008390-199908000-00002","article-title":"Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice","volume":"9","author":"Borner","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/1078-0432.CCR-05-1220","article-title":"BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways","volume":"12","author":"Yang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB4|cit4","first-page":"467","article-title":"Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells","volume":"11","author":"Satyamoorthy","year":"2000","journal-title":"Cell Growth Differ"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1158\/0008-5472.CAN-05-0686","article-title":"Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications","volume":"65","author":"Fernandez","year":"2005","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1471-4159.1983.tb08056.x","article-title":"Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex","volume":"40","author":"Wilk","year":"1983","journal-title":"J Neurochem"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1073\/pnas.96.18.10403","article-title":"Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity","volume":"96","author":"Meng","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1634\/theoncologist.7-1-9","article-title":"Development of the proteasome inhibitor PS-341","volume":"7","author":"Adams","year":"2002","journal-title":"Oncologist"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB9|cit9","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumour agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ijc.11242","article-title":"Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine","volume":"106","author":"Vilella","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00262-003-0495-3","article-title":"Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate","volume":"53","author":"Vilella","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.cmr.0000215039.30812.9b","article-title":"Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines","volume":"16","author":"Mayorga","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"22943","DOI":"10.1074\/jbc.M601025200","article-title":"Switch from caspase-dependent to caspase-independent death during heart development: essential role of endonuclease G in ischemia-induced DNA processing of differentiated cardiomyocytes","volume":"281","author":"Bahi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1093\/emboj\/17.14.3878","article-title":"Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis","volume":"17","author":"Gross","year":"1998","journal-title":"EMBO J"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-05-0676","article-title":"Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells","volume":"65","author":"Qin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/jsbi.2000.4254","article-title":"Review: nuclear events in apoptosis","volume":"129","author":"Robertson","year":"2000","journal-title":"J Struct Biol"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1126\/science.1076194","article-title":"Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans","volume":"298","author":"Wang","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.emboj.7600614","article-title":"Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space","volume":"24","author":"Otera","year":"2005","journal-title":"EMBO J"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/35069004","article-title":"Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death","volume":"410","author":"Joza","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1083\/jcb.200207071","article-title":"Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli","volume":"159","author":"Arnoult","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1083\/jcb.200202130","article-title":"Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death","volume":"158","author":"Cregan","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(04)00120-5","article-title":"The development of proteasome inhibitors as anticancer drugs","volume":"5","author":"Adams","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0092-8674(94)90482-0","article-title":"The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B","volume":"78","author":"Palombella","year":"1994","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB26|cit26","first-page":"4996","article-title":"Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model","volume":"62","author":"LeBlanc","year":"2002","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02893359","article-title":"Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac\/DIABLO from the mitochondria","volume":"12","author":"Nagy","year":"2006","journal-title":"Pathol Oncol Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/cncr.21108","article-title":"A phase II study of bortezomib in the treatment of metastatic malignant melanoma","volume":"103","author":"Markovic","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1158\/0008-5472.CAN-04-0673","article-title":"Augmenting chemosensitivity of malignant melanoma tumours via proteasome inhibition: implication for bortezomib (Velcade, PS-341) as a therapeutic agent for malignant melanoma","volume":"64","author":"Amiri","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1535-7163.985.3.8","article-title":"Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells","volume":"3","author":"Munshi","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1158\/0008-5472.CAN-05-2614","article-title":"Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells","volume":"66","author":"Mlynarczuk-Bialy","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"S2376","DOI":"10.1158\/1078-0432.CCR-05-2558","article-title":"Molecular targets in melanoma from angiogenesis to apoptosis","volume":"12","author":"Sosman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.4049\/jimmunol.176.8.4757","article-title":"Immunosensitization of tumour cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)","volume":"176","author":"Schumacher","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1158\/1078-0432.CCR-03-0561","article-title":"Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors","volume":"10","author":"Pei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB35|cit35","first-page":"207","article-title":"The proteasome inhibitor bortezomib augments anti-proliferative effects of mistletoe lectin-I and the PPAR-gamma agonist rosiglitazone in human melanoma cells","volume":"27","author":"Freudlsperger","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/0008-5472.CAN-06-3377","article-title":"HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest","volume":"67","author":"Jiang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1021\/jm050181l","article-title":"Preliminary studies of new proteasome inhibitors in the tumour targeting approach: synthesis and in vitro cytotoxicity","volume":"48","author":"Vivier","year":"2005","journal-title":"J Med Chem"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjc.6603406","article-title":"A novel proteasome inhibitor NPI-0052 as an anticancer therapy","volume":"95","author":"Chauhan","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1158\/0008-5472.CAN-06-2033","article-title":"Proteasome inhibitor drugs on the rise","volume":"66","author":"Joazeiro","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/156800905774574075","article-title":"Anti-angiogenic and anti-tumour properties of proteasome inhibitors","volume":"5","author":"Daniel","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","article-title":"Induction of apoptosis in fibroblasts by c-myc protein","volume":"69","author":"Evan","year":"1992","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1074\/jbc.M508533200","article-title":"PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells","volume":"281","author":"Yeung","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/35083620","article-title":"Endonuclease G is an apoptotic DNase when released from mitochondria","volume":"412","author":"Li","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1093\/emboj\/cdg423","article-title":"Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax\/Bak-mediated permeabilization","volume":"22","author":"Arnoult","year":"2003","journal-title":"EMBO J"},{"key":"10.1111\/j.1365-2133.2007.08390.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V96.3.1030","article-title":"Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult","volume":"96","author":"Dumont","year":"2000","journal-title":"Blood"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.08390.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.08390.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T12:38:13Z","timestamp":1684240693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/158\/3\/496\/6643796"}},"subtitle":["Effect of proteasome inhibitors on melanoma cells"],"short-title":[],"issued":{"date-parts":[[2008,1,17]]},"references-count":46,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08390.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,17]]}}}